Citizens analyst Jonathan Wolleben upgraded Annexon Biosciences (NASDAQ: ANNX) from Market Underperform to Market Perform.The analyst comments: “Adding vision preservation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE